From Tpr-Met to Met, tumorigenesis and tubes

被引:133
作者
Peschard, P.
Park, M. [1 ]
机构
[1] McGill Univ, Ctr Hlth, Mol Oncol Grp, Dept Biochem, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Ctr Hlth, Mol Oncol Grp, Dept Med, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Ctr Hlth, Mol Oncol Grp, Dept Oncol, Montreal, PQ H3A 1A1, Canada
关键词
signaling; downregulation; ubiquitination; mutations; oncogenic activation;
D O I
10.1038/sj.onc.1210201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The receptor for hepatocyte growth factor (HGF)/scatter factor (SF), Met, controls a program of invasive epithelial growth through the coordination of cell proliferation and survival, cell migration and epithelial morphogenesis. This process is important during embryogenesis and for organ regeneration in the adult. However, when deregulated the HGF/SF-Met signaling axis contributes to tumorigenesis and metastasis. Studies on the oncogenic activation of the Met receptor have shed light on the molecular mechanisms underlying the oncogenic activation of receptor tyrosine kinase (RTKs). More than a decade ago, work on the Met related oncogene, Tpr-Met, revealed the mechanism for activation of RTK-derived oncogenes generated following chromosomal translocation. More recently, studies on the mechanisms of downregulation of the Met RTK highlight a role for loss of downregulation in RTK oncogenic activation.
引用
收藏
页码:1276 / 1285
页数:10
相关论文
共 114 条
[1]   Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation [J].
Abella, JV ;
Peschard, P ;
Naujokas, MA ;
Lin, T ;
Saucier, C ;
Urbé, S ;
Park, M .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) :9632-9645
[2]   Defective downregulation of receptor tyrosine kinases in cancer [J].
Bache, KG ;
Slagsvold, T ;
Stenmark, H .
EMBO JOURNAL, 2004, 23 (14) :2707-2712
[3]   Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors [J].
Bao, J ;
Gur, G ;
Yarden, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2438-2443
[4]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[5]   Met provides essential signals for liver regeneration [J].
Borowiak, M ;
Garratt, AN ;
Wüstefeld, T ;
Strehle, M ;
Trautwein, C ;
Birchmeier, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (29) :10608-10613
[6]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[7]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[8]   From UBA to UBX: new words in the ubiquitin vocabulary [J].
Buchberger, A .
TRENDS IN CELL BIOLOGY, 2002, 12 (05) :216-221
[9]   The Met receptor degradation pathway -: Requirement for Lys48-linked polyubiquitin independent of proteasome activity [J].
Carter, S ;
Urbé, S ;
Clague, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :52835-52839
[10]   MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE [J].
COOPER, CS ;
PARK, M ;
BLAIR, DG ;
TAINSKY, MA ;
HUEBNER, K ;
CROCE, CM ;
VANDEWOUDE, GF .
NATURE, 1984, 311 (5981) :29-33